The City of Charlotte is suing pharmaceutical companies over inflated insulin prices, alleging they have overpaid millions for the medicine through their employee health plans.

Pharmacies in Omaha are sending patients to other locations to find what they need as insulin is on back order throughout the ...

The new CalRx insulin will hit the market in January at $55 a month, part of a broader state effort to rein in drug costs.

Medtronic initially secured FDA clearance for the MiniMed 780G pump for people with Type 1 diabetes in early 2023. This past ...

And the market for insulin has changed fast. Since 2023, drug companies have cut costs voluntarily, spurred by government ...

Inhaled insulin shows safety and high treatment satisfaction in youth with type 1 diabetes over 26 weeks but does not meet ...

McGill University researchers have identified a brain function that helps explain why childhood stress raises metabolic ...

California lawmakers and Gov. Gavin Newsom have approved more than 900 new laws that will begin to take effect starting on Jan. 1, 2025. They include measures to cap insulin co-pays, ban cat declawing ...

More than a million Americans with diabetes may be skipping insulin doses or delaying purchase of the drug because of its expense, said authors of a new study. Based on data from 982 insulin users ...

Scientists at the University of Wisconsin–Madison have uncovered a possible way to protect key cells in the pancreas that are ...

This review synthesizes evidence that gut microbiota dysbiosis contributes to insulin resistance and symptom severity in ...

Unlike our organs, cell organelles such as mitochondria are not fixed in place, but when, where, how, and why organelles move ...